Cortellis statistics

info info

Citations per year

info

Tool usage distribution map

info info

Associated diseases

info

Popular tool citations

chevron_left Unclassified tools chevron_right
Want to access the full stats & trends on this tool?

Cortellis specifications

Information


Unique identifier OMICS_33503
Name Cortellis
Interface Web user interface
Restrictions to use License purchase required
License Commercial
Computer skills Basic
Stability Stable
High performance computing Yes
Registration required Yes
Maintained Yes

Cortellis citations

 (12)
library_books

The research status of immune checkpoint blockade by anti CTLA4 and anti PD1/PD l1 antibodies in tumor immunotherapy in China

2018
PMCID: 5908611
PMID: 29642147
DOI: 10.1097/MD.0000000000010276

[…] According to a Cortellis CI search result, 30 drugs that targeted CTLA-4, 37 drugs that targeted PD-1, and 2 drugs that targeted both CTLA-4 and PD-1, have been tested worldwide.Three drugs that targeted CTLA-4 were […]

library_books

An assessment of the factors affecting the commercialization of cell based therapeutics: a systematic review protocol

2017
Syst Rev
PMCID: 5485574
PMID: 28651620
DOI: 10.1186/s13643-017-0517-4

[…] references of papers electronically identified in the database searches and through further exploration of gray literature (Tables and ). Key data regarding electronic database and Thomson Reuters Cortellis™ searches is provided below.The above electronic databases were first accessed on 17 November 2015.Key words and medical subheadings:Subheadings: cell therapy; biomedical technology assessme […]

library_books

Clinical application of a cancer genomic profiling assay to guide precision medicine decisions

2017
PMCID: 5580078
PMID: 28890729
DOI: 10.2217/pme-2017-0011

[…] -approved drug, a target of a drug in clinical development or confers resistance to known treatments. Clinical trials are identified using the ClinicalTrials.gov and other tools (e.g., Thomson Reuter Cortellis and Pharma Intelligence Trialtrove). […]

library_books

Institutional profile: the national Swedish academic drug discovery and development platform at SciLifeLab

2017
PMCID: 5481862
PMID: 28670468
DOI: 10.4155/fsoa-2017-0013

[…] /databases for safety assessment of targets and compounds. Analytical support on the pharma industry is provided via Informa CiteLine® and Trial Trove® (London, UK) and Thomson Reuters Integrity® and Cortellis® (Toronto, Canada). […]

library_books

Functional Genomics Identifies Tis21 Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh Type Development

2016
Front Pharmacol
PMCID: 5127835
PMID: 27965576
DOI: 10.3389/fphar.2016.00449

[…] ial drug targets among the Set A differentially expressed genes, we have used the drug target selection tool via gene list analysis by MetaCore™ (Thomson Reuters) (Ekins et al., ) and Thomson Reuters Cortellis Drug Viewer tool (also available on MetaCore™ platform) via pathway analysis. The search has been performed among human primary/direct (Table ) and secondary/indirect (Table ) drug targets ( […]

library_books

A Mini Review for Cancer Immunotherapy: Molecular Understanding of PD 1/PD L1 Pathway and Translational Blockade of Immune Checkpoints

2016
Int J Mol Sci
PMCID: 4964524
PMID: 27438833
DOI: 10.3390/ijms17071151

[…] China has overtaken India becoming the largest biosimilar discovering country from Cortellis Competitive Intelligence, according to Thomson Reuters report in 2015. It mirror the investment environment’s expectation to Chinese biosimilars. There is no doubt that the development of bi […]


Want to access the full list of citations?
Cortellis institution(s)
Clarivate Analytics, Philadelphia, PA, USA

Cortellis reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Cortellis